Novartis and Novo helped provide $40m for the autoimmune disease therapy developer that supported its acquisition of joint venture Kanyos Bio.

Praktikertjänst-backed Aprea Therapeutics has filed for a $68.3m initial public offering that will fund the clinical progress of its cancer drug candidates.

The immuno-oncology drug developer, which counts numerous pharmaceutical firms among its investors, has filed for a $100m offering in the US.

The corporate has bought portfolio company Kazan Networks three years after a series A round that also included Samsung Ventures and Intel Capital.

Microsoft and Qvest Media are set to exit video livestreaming technology developer in an acquisition by LTN Global.

Fosun Pharma is in line to exit Shanghai Henlius Biotech, which has set a price range for an offering that could raise up to $477m.

Spirogen spinoff ADC will put the proceeds into advancing its cancer-fighting antibody drug conjugates, having raised more than $530m from backers including AstraZeneca.

Photo copyright services platform Binded is set to be bought by Pixsy in a transaction allowing media group Asahi Shimbun to exit.

Emtek could potentially exit online real estate platform PropertyGuru, which is reportedly preparing an initial public offering in Australia.

Shopify has agreed to pay $450m in cash and shares for the warehouse technology developer, which had raised $46m from investors including iRobot.